Clinical Study Results
Adverse events
There were 27.8% of participants who had adverse events during the study. This was 10 out of 36 participants.

The table below shows how many participants had adverse events during the study.

Adverse events during the study
10 mg of benralizumab (out of 12 participants)
30 mg of benralizumab (out of 12 participants)
100 mg of benralizumab (out of 12 participants)

How many participants had adverse events?
25.0% (3)
41.7% (5)
16.7% (2)

How many participants had serious adverse events?
0.0% (0)
0.0% (0)
8.3% (1)

How many participants left the study due to adverse events?
0.0% (0)
0.0% (0)
0.0% (0)